Vaginal oxygen and hyaluronic acid for genito-urinary symptoms of breast cancer survivors. One-year follow-up study
Year: 2026
Type: article
Abstract: Backgrounds To investigate in breast cancer survivors on adjuvant hormone therapy the persistence up to 1 year of the modifications of genito-urinary symptoms associated with the use of vaginal oxygen and hyaluronic acid. Methods Single centre prospective observational study with a follow-up period of 12 months performed on women enrolled between July 2020 and July 2024. Each woman every 15 days for 5 times received an applications of vaginal oxygen and hyaluronic acid. At each single treatment intravaginal oxygen was administered for 15 min. In the last 5 min oxygen was co-administered with a 0.2% sodium hyalurate solution. Modifications associated with treatments were evaluated at the end of treatment and 1, 3 and 12 months since treatment termination. The modification of the vaginal health index score (VHIS) was the primary objective of the study. Secondary objectives were modifications of the visual analogue scale value (VAS) of vaginal burning and dyspareunia, of the female sexual function inventory score (FSFI) and of the short-form of the urinary distress inventory-6 score (UDI-6). Results Sixty-five breast cancer survivors were included between July 2021 and July 2024. During treatment we observed an improvement ( p = 0.005) of VHIS and FSFI, and a decrease ( p = 0.005) of dyspareunia, burning and UDI-6 score. After 12 months VHIS (13.4 ± 2.5 vs. 9.6 ± 2.5) and FSFI (13.9 ± 9.5 vs. 10.0 ± 7.4), remained higher ( p = 0.005), dyspareunia (6.5 ± 2.8 vs. 8.7 ± 1.4 p = 0.005) and burning (3.4 ± 3.1 vs. 6.1 ± 2.7) lower ( p = 0.005) than at baseline, while the UDI-6 scores returned to baseline values. Conclusions Genito-urinary symptoms of breast cancer survivors on adjuvant endocrine therapy improved following vaginal oxygen and hyaluronic acid. After 12 months improvements were conserved on sexuality, attenuated on vaginal atrophy, dyspareunia and vaginal burning, and lost on lower urinary tract disturbances.
Source: Frontiers in Reproductive Health
Authors: Angelo Cagnacci(Conceptualization, Data curation, Project administration, Supervision, Writing – original draft, Writing – review & editing), Giorgia Asinaro(Data curation, Investigation, Writing – original draft, Writing – review & editing), Giorgia Spirito-Rosevich(Data curation, Investigation, Writing – original draft, Writing – review & editing), Matteo Lambertini(Investigation, Writing – original draft, Writing – review & editing), Lucia del Mastro, Ambrogio Pietro Londero(Formal analysis, Writing – original draft, Writing – review & editing), Claudia Massarotti(Data curation, Investigation, Writing – original draft, Writing – review & editing)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,077
OpenAlex ID: W7237214782
